A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer - Concepedia

Concepedia

Publication | Closed Access

A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer

125

Citations

12

References

2015

Year

Felix Dietlein, Bastian Kalb, Mladen Jokić, Elisa M. Noll, Alexander Strong, Lars Tharun, Luka Ozretić, Helen Künstlinger, Kato Kambartel, Winfried Randerath,

Tumor BiologyRadiation OncologySynergistic InteractionReceptor Tyrosine KinaseMk2 InhibitorsKras-mutant CancerTumor SuppressorSystems BiologyMedicineCell BiologyCell SignalingTumor MicroenvironmentCancer Research

References

	Year	Citations

Page 1

Page 1